• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南澳大利亚的脑膜炎球菌病:1971 - 1980年的发病率和血清群分布

Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980.

作者信息

Hansman D

出版信息

J Hyg (Lond). 1983 Feb;90(1):49-54. doi: 10.1017/s0022172400063828.

DOI:10.1017/s0022172400063828
PMID:6401776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2134198/
Abstract

During the ten-year period 1971-80 isolates of meningococci from 85 cases of meningococcal disease (MD) in South Australia, from 66 children, 6 adolescents and 13 adults, were examined. These comprised 69 cases of meningitis and 16 cases of bacteraemia without meningitis. Thirty-three (39%) of all cases of MD occurred in children less than 1 year of age, the median age was 19 months. Serogroup B accounted for 61 (72%) cases of MD, group A seven (8%), group C seven (8%), group W135 five (6%), group Y three (4%) and group X one (1%); in addition there was a single case of Neisseria lactamica infection. The annual prevalence of MD in South Australia for the period was 11 cases per 100000 for children under the age of 2 years and 0.7 cases per 100000 overall. The prevalence was highest in winter (45% cases) and spring (26%) and lowest in summer (13%). The overall mortality rate was 8%. Four of the 21 infants under the age of 6 months died (mortality rate 19%) whereas none of the 32 children aged from 6 months to 14 years died (P = 0.02). Amongst the survivors, three children had deafness, which was bilateral and severe in two.

摘要

在1971年至1980年的十年间,对南澳大利亚州85例脑膜炎球菌病(MD)患者的分离脑膜炎球菌进行了检查,这些患者包括66名儿童、6名青少年和13名成人。其中有69例脑膜炎患者和16例无脑膜炎的菌血症患者。所有MD病例中,33例(39%)发生在1岁以下儿童,中位年龄为19个月。B血清群占MD病例的61例(72%),A群7例(8%),C群7例(8%),W135群5例(6%),Y群3例(4%),X群1例(1%);此外,还有1例乳酸奈瑟菌感染病例。该时期南澳大利亚州2岁以下儿童MD的年患病率为每100000人中有11例,总体年患病率为每100000人中有0.7例。患病率在冬季最高(占病例的45%),春季次之(26%),夏季最低(13%)。总体死亡率为8%。21名6个月以下婴儿中有4名死亡(死亡率19%),而32名6个月至14岁的儿童均未死亡(P = 0.02)。在幸存者中,有3名儿童失聪,其中2名是双侧严重失聪。

相似文献

1
Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980.南澳大利亚的脑膜炎球菌病:1971 - 1980年的发病率和血清群分布
J Hyg (Lond). 1983 Feb;90(1):49-54. doi: 10.1017/s0022172400063828.
2
Meningococcal disease in urban south western Sydney, 1990-1994.1990 - 1994年悉尼西南部城区的脑膜炎球菌病
Aust N Z J Med. 1996 Aug;26(4):526-32. doi: 10.1111/j.1445-5994.1996.tb00599.x.
3
Australian Meningococcal Surveillance Programme annual report, 2010.《2010年澳大利亚脑膜炎球菌监测计划年度报告》
Commun Dis Intell Q Rep. 2011 Sep;35(3):217-28.
4
Meningococcal serogroups in New South Wales, 1977-1987.
Med J Aust. 1988 Oct 3;149(7):360-2. doi: 10.5694/j.1326-5377.1988.tb120668.x.
5
Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.1959 - 1983年荷兰脑膜炎球菌血清群与疾病病程的关联
Bull World Health Organ. 1987;65(6):861-8.
6
Annual report of the Australian Meningococcal Surveillance Programme, 2003.《2003年澳大利亚脑膜炎球菌监测项目年度报告》
Commun Dis Intell Q Rep. 2004;28(2):194-206. doi: 10.33321/cdi.2004.28.17.
7
Annual report of the Australian Meningococcal Surveillance Programme, 2011.《2011年澳大利亚脑膜炎球菌监测计划年度报告》
Commun Dis Intell Q Rep. 2012 Sep 30;36(3):E251-62.
8
Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile.智利伊基克B群脑膜炎球菌病的血清型特异性暴发。
Epidemiol Infect. 1990 Aug;105(1):119-26. doi: 10.1017/s0950268800047713.
9
Recent emergence of serogroup C meningococcal disease in Greece.希腊近期出现C群脑膜炎球菌病。
FEMS Immunol Med Microbiol. 1999 Jan;23(1):49-55. doi: 10.1111/j.1574-695X.1999.tb01716.x.
10
Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.1999 年 6 月至 2011 年 6 月期间荷兰侵袭性脑膜炎奈瑟菌病的疾病负担:血清群和克隆复合物的主观作用。
Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

引用本文的文献

1
Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis.全球 80 年间细菌性脑膜炎的病死率:系统评价和荟萃分析。
JAMA Netw Open. 2024 Aug 1;7(8):e2424802. doi: 10.1001/jamanetworkopen.2024.24802.
2
Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review.由W群血清型侵袭性脑膜炎球菌病引起的临床表现范围:一项系统综述
Infect Dis Ther. 2023 Oct;12(10):2337-2351. doi: 10.1007/s40121-023-00869-z. Epub 2023 Sep 26.
3
Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.1992-2022 年巴西侵袭性脑膜炎奈瑟菌 X 分离株的基因组特征。
Int Microbiol. 2023 Aug;26(3):611-618. doi: 10.1007/s10123-023-00325-5. Epub 2023 Jan 10.
4
A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.关于脑膜炎球菌病的W、X、Y、E和NG型的叙述性综述:新兴荚膜群、致病型及全球防控
Microorganisms. 2021 Mar 3;9(3):519. doi: 10.3390/microorganisms9030519.
5
Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.澳大利亚两个州(维多利亚州和西澳大利亚州)脑膜炎奈瑟菌种群结构的差异。
PLoS One. 2017 Oct 24;12(10):e0186839. doi: 10.1371/journal.pone.0186839. eCollection 2017.
6
Neisseria meningitidis serogroup X sequence type 767 in Turkey.土耳其的X群脑膜炎奈瑟菌序列型767
J Clin Microbiol. 2010 Nov;48(11):4340-1. doi: 10.1128/JCM.01417-10. Epub 2010 Aug 25.
7
Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.脑膜炎奈瑟菌X血清群(α1→4)连接的N-乙酰-D-葡糖胺1-磷酸荚膜生物合成的遗传基础。
Infect Immun. 2003 Dec;71(12):6712-20. doi: 10.1128/IAI.71.12.6712-6720.2003.
8
Clonal groupings in serogroup X Neisseria meningitidis.血清群X脑膜炎奈瑟菌中的克隆分组
Emerg Infect Dis. 2002 May;8(5):462-6. doi: 10.3201/eid0805.010227.
9
Mortality in the years following bacterial meningitis.
Infection. 1986 Mar-Apr;14(2):55-9. doi: 10.1007/BF01644442.
10
Meningococcal infection in children.儿童的脑膜炎球菌感染
Ir J Med Sci. 1988 Aug;157(8):258-60. doi: 10.1007/BF02948282.

本文引用的文献

1
Meningococcal disease in Scandinavia.斯堪的纳维亚半岛的脑膜炎球菌病。
Br Med J (Clin Res Ed). 1982 May 29;284(6329):1618-21. doi: 10.1136/bmj.284.6329.1618.
2
Prevention of meningococcal disease by group C polysaccharide vaccine.C群多糖疫苗预防脑膜炎球菌病
N Engl J Med. 1970 Feb 19;282(8):417-20. doi: 10.1056/NEJM197002192820803.
3
Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.人类对脑膜炎球菌的免疫力。IV. A群和C群脑膜炎球菌多糖对人类志愿者的免疫原性。
J Exp Med. 1969 Jun 1;129(6):1367-84. doi: 10.1084/jem.129.6.1367.
4
Some recollections of the meningococcal diseases. The first Harry F. Dowling lecture.关于脑膜炎球菌疾病的一些回忆。首届哈里·F·道林讲座。
JAMA. 1972 May 22;220(8):1107-12.
5
Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil.巴西圣保罗由C群脑膜炎奈瑟菌引起的流行病
J Infect Dis. 1974 May;129(5):568-71. doi: 10.1093/infdis/129.5.568.
6
Meningitis caused by Neisseria lactamica.由乳酸奈瑟菌引起的脑膜炎。
N Engl J Med. 1978 Aug 31;299(9):491.
7
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features.尼日利亚北部扎里亚的脑膜炎球菌感染疫情。1. 一般流行病学特征。
Trans R Soc Trop Med Hyg. 1979;73(5):557-62. doi: 10.1016/0035-9203(79)90052-x.
8
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.A群脑膜炎球菌多糖疫苗在3个月至5岁儿童中的临床疗效。
N Engl J Med. 1977 Sep 29;297(13):686-91. doi: 10.1056/NEJM197709292971302.